Biophytis (EPA:ALBPS) | WebDisclosure

Basculer en Français

9480	Companies
185563	Keywords
117965	Articles
99397	Press releases

Home
Companies
Biophytis

REGULATED PRESS RELEASE

published on 03/26/2025 at 07:35, 8 months 10 days ago

Biophytis announces the successful completion of a €2,6 million private placement
Biophytis successfully completes €2.6M private placement, aiming to accelerate clinical programs and partnerships, strengthen corporate purposes, and extend cash runway

Private Placement Biophytis Biotechnology Fundraising Clinical Programs
REGULATED PRESS RELEASE

published on 03/26/2025 at 07:35, 8 months 10 days ago

Biophytis annonce le succès d'un placement privé d'environ 2,6 millions d'euros
Biophytis annonce le succès d'un placement privé d'environ 2,6 millions d'euros. Augmentation de capital pour accélérer le développement de traitements et soutenir les activités de recherche et de partenariats

Biophytis Placement Privé Augmentation De Capital Investisseurs Recherche Médicale
BRIEF

published on 03/24/2025 at 07:35, 8 months 12 days ago

Biophytis : Nouvelles Avancées dans le Traitement de l'Obésité

Biophytis Mobilite BIO101 Obésité GLP-1
BRIEF

published on 03/24/2025 at 07:35, 8 months 12 days ago

Biophytis Reveals New Preclinical Findings on Obesity Treatment

Biophytis Obesity Treatment GLP-1 Preclinical Results Muscle Strength
REGULATED PRESS RELEASE

published on 03/24/2025 at 07:30, 8 months 12 days ago

Biophytis annonce de nouvelles données non cliniques renforçant sa mission de pionnier dans la restauration de la mobilité chez les patients souffrant d’obésité.
Biophytis annonce de nouvelles données non cliniques renforçant sa mission de pionnier dans la restauration de la mobilité chez les patients souffrant d'obésité

Biophytis Mobilite Obésité Étude Préclinique Force Musculaire
REGULATED PRESS RELEASE

published on 03/24/2025 at 07:30, 8 months 12 days ago

Biophytis announces new non-clinical data further supporting its mission to pioneer the restoration of mobility in patients with obesity
Biophytis announces new preclinical study results showing combination of BIO101 and GLP-1 restores muscle strength and mobility in obesity patients. The company aims to pioneer mobility restoration in obese patients

Biophytis Preclinical Study BIO101 Obesity GLP-1
BRIEF

published on 03/17/2025 at 07:05, 8 months 19 days ago

Biophytis Publishes Promising Sarcopenia Trial Results

Biophytis Clinical Trial Sarcopenia BIO101 Phase 2 Results
BRIEF

published on 03/17/2025 at 07:05, 8 months 19 days ago

Biophytis avance dans le traitement de la sarcopénie

Biophytis Essais Cliniques Sarcopénie BIO101 Phase III
REGULATED PRESS RELEASE

published on 03/17/2025 at 07:00, 8 months 19 days ago

Biophytis révolutionne la sarcopénie
Biophytis révolutionne la sarcopénie avec BIO101. Résultats prometteurs de l'étude SARA-INT publiés. Passage à la Phase 3 confirmé. Importante avancée dans le traitement de la sarcopénie

Biophytis Traitement Étude Clinique Sarcopénie BIO101
REGULATED PRESS RELEASE

published on 03/17/2025 at 07:00, 8 months 19 days ago

Biophytis revolutionizes sarcopenia
Biophytis announces groundbreaking results from SARA-INT Phase II trial for BIO101 in sarcopenia, confirming Phase 3 readiness. Publication in JCSM highlights efficacy and safety

Biophytis Clinical Trial Sarcopenia Phase II SARA-INT

Accesswire

Published on 12/06/2025 at 00:00, 20 minutes ago

Bird River Announces Closing of $0.10 Common Share Financing
Published on 12/05/2025 at 23:30, 50 minutes ago

55 North Mining Inc. Announces Completion of Third and Final Tranche of Private Placement for a Total of $4,202,000
Published on 12/05/2025 at 22:50, 1 hour 30 minutes ago

Banyan Gold Grants Incentive Stock Options
Published on 12/05/2025 at 21:45, 2 hours 35 minutes ago

When the Architecture Becomes Visible: The SMX Revaluation Explained
Published on 12/05/2025 at 21:30, 2 hours 50 minutes ago

The Identity Layer Beneath Everything: Why Markets Are Revaluing SMX All at Once

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 22:15, 2 hours 4 minutes ago

CPI PROPERTY GROUP - Changes in Shareholding and Board of Directors
Published on 12/05/2025 at 22:12, 2 hours 8 minutes ago

EQS-Adhoc: CPI PROPERTY GROUP - Change to Distribution Policy
Published on 12/05/2025 at 18:58, 5 hours 22 minutes ago

EQS-Adhoc: HORNBACH Holding AG & Co. KGaA: Reduced earnings in Q3 2025/26 – Guidance for adjusted EBIT at previous year’s level still valid
Published on 12/05/2025 at 18:26, 5 hours 53 minutes ago

POS-Transaction in Own Shares
Published on 12/05/2025 at 18:15, 6 hours 4 minutes ago

Completion of merger to form Helvetia Baloise Holding Ltd

Les Echos

Published on 12/05/2025 at 23:00, 1 hour 20 minutes ago

ALTAREIT : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 12/05/2025 at 23:00, 1 hour 20 minutes ago

ALTAREA : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 12/05/2025 at 23:00, 1 hour 20 minutes ago

ALTAREA : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES NOVEMBRE 2025
Published on 12/05/2025 at 23:00, 1 hour 20 minutes ago

ALTAREIT : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES NOVEMBRE 2025
Published on 12/05/2025 at 17:18, 7 hours 2 minutes ago

La vidéo de la réunion de présentation des résultats 2024-2025 du 5 décembre 2025 est disponible

View all LES ECHOS COMFI WIRE